Get All Access for FREE

Market News & Research,
Fundamental Data,
Live Transcripts & Audio,
AlphaGraphics,

and a whole lot more…

{{::item.ticker}} • {{::item.company_name}} No Results

Get All Access for FREE

Market News & Research,
Fundamental Data,
Live Transcripts & Audio,
AlphaGraphics,

and a whole lot more…

News & Research
Portfolio
Discover
Groups
$DGX {{ '2017-10-19T14:18:39+0000' | timeago}} • Infographic

$DGX Quest Diagnostics Incorporated Earnings AlphaGraphic: Q3 2017 Highlights

$DGX {{ '2018-05-11T17:19:37+0000' | timeago}} • Infographic

$DGX Quest Diagnostics Earnings AlphaGraphic: Q1 2018 Highlights

$DGX {{ '2018-02-05T15:52:53+0000' | timeago}} • Infographic

$DGX Quest Diagnostics Incorporated Earnings AlphaGraphic: Q4 2017 Highlights

$DGX {{ '2017-12-12T17:19:29+0000' | timeago}} • Announcement

$DGX completed the previously announced acquisition of the Shiel Medical Laboratory business from Fresenius Medical Care, the company focused on delivering care to people with renal and other chronic conditions.

$DGX {{ '2017-12-01T19:47:03+0000' | timeago}} • Announcement

$DGX said it completed the acquisition of Cleveland HeartLab. Pursuant to the deal, Quest has entered into collaboration with Cleveland Clinic to speed up commercialization of emerging innovations at Cleveland, including its Lerner Research Institute. The companies also plan to collaborate on clinical trials.

$DGX {{ '2017-11-29T12:27:19+0000' | timeago}} • Announcement

$DGX has declared a quarterly cash dividend of $0.45 per share on its common stock. The dividend is payable on January 24, 2018, to shareholders of record on January 9, 2018.

$DGX {{ '2017-10-19T15:30:33+0000' | timeago}} • Announcement

$DGX narrowed its FY17 outlook due to the impact of hurricanes in 3Q17. Revenue is now expected to be about $7.71Bil from the previous guidance of $7.69-7.74Bil. GAAP EPS is now expected in the range of $4.87-4.92, down from the earlier range of $4.90-5.00. On an adjusted basis, $DGX narrowed its FY17 EPS outlook to $5.62-5.67.

$DGX {{ '2017-10-19T15:24:48+0000' | timeago}} • Announcement

$DGX earnings plunged for 3Q17 on operating income decline and expense increase. Net earnings declined 16.1% to $161MM or $1.15 per share from $192MM or $1.34 per share a year earlier. Revenue for the quarter rose 2.4% to $1.93Bil. On an adjusted basis, $DGX earned $1.39 per share.

$DGX {{ '2017-10-19T14:18:39+0000' | timeago}} • Infographic

$DGX Quest Diagnostics Incorporated Earnings AlphaGraphic: Q3 2017 Highlights

$DGX {{ '2017-10-18T21:05:30+0000' | timeago}} • Announcement

Medical diagnostic company $DGX has agreed to acquire Cleveland HeartLab from equity investors. The company intends to set up a national center of excellence in diagnostic information services at Cleveland HeartLab's laboratory. The all-equity transaction is expected to close in 4Q17. The financial details of the deal were not disclosed.

$DGX {{ '2017-09-29T14:36:00+0000' | timeago}} • Announcement

Diagnostics firm $DGX acquired the outreach lab services operations of William W Backus Hospital and The Hospital of Central Connecticut, both run by Hartford HealthCare. The acquisition is expected to enable physicians and patients to directly access Quest's broader range of testing services. Financial terms of the deal were not disclosed

$DGX {{ '2017-09-28T13:31:56+0000' | timeago}} • Announcement

$DGX, provider of diagnostic information services, has announced an agreement under which it will acquire the Shiel Medical Laboratory business from $FMS. The transaction is structured as a purchase of assets and expected to be completed in 4Q17. Financial terms were not disclosed.

$DGX {{ '2017-09-27T20:44:38+0000' | timeago}} • Announcement

Diagnostic information services provider $DGX said it expects a 1.5% reduction in revenues and a $0.10 per share impact on both reported and adjusted earnings in 3Q17, due to the recent hurricanes.  The impact of the hurricanes is primarily attributable to operations in Florida and Texas, where the company has a large presence.

$DGX {{ '2017-08-18T14:15:24+0000' | timeago}} • Announcement

$DGX declared a quarterly cash dividend of $0.45 per share, payable on Oct 18, 2017 to shareholders as on Oct 3, 2017.

$DGX {{ '2017-07-18T13:54:10+0000' | timeago}} • Announcement

Medical diagnostics firm $DGX has completed the acquisition of laboratory businesses Med Fusion and Clear Point. They form the basis for Quest’s first national center of excellence in precision diagnostics for oncology. The company is now a preferred provider to several organizations that are formerly owners of one or both of the acquired entities.

$DGX {{ '2017-06-27T17:25:22+0000' | timeago}} • Announcement

$DGX signed a nonbinding letter of intent to buy the outreach laboratory services business of Cape Cod Healthcare (CCHC) for undisclosed terms. Upon approval by the Massachusetts Health Policy Commission, the organizations expect to complete the transaction by Jan. 1, 2018.

$DGX {{ '2017-06-12T20:40:28+0000' | timeago}} • Announcement

$DGX to acquire two laboratory businesses in Lewisville, Texas, aiming to establish a center of excellence providing diagnostic services to aid the detection and management of cancer for oncologists and patients. Upon transaction completion, $DGX will be a preferred provider of advanced oncology diagnostics for US Oncology Network.

$DGX {{ '2017-05-16T16:20:25+0000' | timeago}} • Announcement

$DGX declared a quarterly cash dividend of $0.45 per share, payable on July 24, 2017 to shareholders of record of Quest Diagnostics common stock on July 10, 2017.

$DGX {{ '2017-04-20T14:12:14+0000' | timeago}} • Webcast

$DGX said that its partnership with their computing partner $IBM is progressing well in oncology business. The company said that it uses IBM Watson Health in the cancer treatment. $DGX believes IBM's sales force and their presence with integrated delivery systems will help the company.

$DGX {{ '2017-04-20T13:45:15+0000' | timeago}} • Webcast

$DGX said that its relationship with United Healthcare, which was announced in 4Q16, is progressing well. The company is working with United in wellness and professional laboratory services businesses. $DGX believes that its relationship with United will get stronger over time.

$DGX {{ '2017-04-20T12:38:29+0000' | timeago}} • Announcement

$DGX raised its outlook for EPS in FY17 to $4.73-4.88 from the previous guidance of $4.65-4.80. Adjusted EPS was also raised to $5.45-5.60. The upgrades reflect higher-than-expected excess tax benefit related to stock-based compensation in 1Q17.

Recent Transcripts
ENZ | Earnings
June 12th 2018, 12:30pm
COO | Earnings
June 7th 2018, 9:00pm
ONVO | Earnings
May 31st 2018, 9:00pm
PTN | Earnings
May 15th 2018, 3:00pm
AlphaGraphics you may like
Related Feed
Recent Transcripts
ENZ | Earnings
June 12th 2018, 12:30pm
COO | Earnings
June 7th 2018, 9:00pm
ONVO | Earnings
May 31st 2018, 9:00pm
PTN | Earnings
May 15th 2018, 3:00pm
AlphaGraphics you may like